Review: Exteroceptive Sensory Abnormalities in Childhood and Adolescent Anxiety and Obsessive-Compulsive Disorder: A Critical Review - 24/12/19
, Dan J. Stein, MD, PhD c, Bernadette M. Cortese, PhD aAbstract |
Objective |
Childhood anxiety and obsessive-compulsive disorder (OCD) are defined by fear, worry, and uncertainty, but there is also evidence that affected children possess exteroceptive sensory abnormalities. These sensory features may often instigate symptoms and cause significant distress and functional impairment. In addition, a purported class of conditions known as “sensory processing disorders” may significantly overlap with childhood anxiety and OCD, which provides further support for a connection between abnormal sensation and fear-based psychopathology.
Method |
The current review was conducted to synthesize and to critically evaluate the existing research on exteroceptive sensory abnormalities in childhood anxiety and OCD. Because of the paucity of research in this area, studies with adult populations were also briefly reviewed.
Results |
The review found significant support for the notion that sensory abnormalities are common in children with anxiety disorders and OCD, but there are significant limitations to research in this area that prevent firm conclusions.
Conclusion |
Potential avenues for future research on sensory features of pediatric anxiety and OCD are discussed.
Le texte complet de cet article est disponible en PDF.Key words : psychosomatics, sensory processing, childhood psychopathology, anxiety, OCD
Plan
| The authors have reported no funding for this work. |
|
| This article is part of a special series devoted to the subject of anxiety and OCD. The series covers current topics in anxiety and OCD, including epidemiology, translational neuroscience, and clinical care. The series was edited by Guest Editor Daniel A. Geller, MBBS, FRACP. |
|
| Disclosure: Dr. Stein has received research grants and/or consultancy honoraria from Abbott, ABMRF, AstraZeneca, Biocodex, Eli Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson and Johnson, Lundbeck, the National Responsible Gambling Foundation, Novartis, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. Drs. Houghton and Cortese have reported no biomedical financial interests or potential conflicts of interest. |
Vol 59 - N° 1
P. 78-87 - janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
